文献速递认知障碍与谵妄衰弱、肌少症与跌倒

住院老年人磁共振波谱显示年龄与谵妄相关代谢改变

Magnetic resonance spectroscopy in hospitalised older people shows age and delirium-specific metabolic changes.
PubMed 文献 · Age Ageing · 2026-01-01

一项前瞻性病例对照研究对38名≥65岁内科住院患者行1H-磁共振波谱,25人完成方案。谵妄组(n=13)入院前衰弱程度高于非谵妄组(n=12),校正白质病变后谷氨酸更高(P=0.024);谷氨酰胺随年龄升高、随皮质萎缩降低,肌醇随年龄降低、随ADC中位数升高。结论提示谵妄以脑谷氨酸升高为特征。

要点

  • 校正MRS体素ADC后,谵妄组谷氨酸浓度更高(P=0.024)。
  • 其余代谢物浓度未见组间差异;谷氨酰胺随年龄升高、随皮质萎缩降低。

核心结论

  • 结果提示谵妄以脑谷氨酸浓度升高为特征。
  • 谷氨酸升高可能引起兴奋性毒性脑损伤,并促发谵妄后认知下降,且为潜在可干预过程,值得进一步研究。

研究设计与样本

  • 前瞻性病例对照研究,纳入≥65岁伴或不伴谵妄(DSM-5)的内科住院患者。
  • 评估病情严重程度、衰弱与既往认知下降;用1H-磁共振波谱测顶叶白质代谢物浓度,并用弥散MRI以ADC评估结构改变。
  • 38名参与者中25人完成MRS方案(13男12女,平均年龄80.5岁,SD=6.47)。

主要发现

  • 谵妄组(n=13)入院前衰弱程度高于非谵妄组(n=12)(临床衰弱量表中位数5 vs 4.5;P=.049)。
  • 年龄、性别、MRS质量指标、萎缩与白质病变组间无显著差异。
  • 以MRS体素ADC校正白质病变效应的通用线性模型中,谵妄组谷氨酸更高(P=0.024)。
  • 其他代谢物浓度未见组间差异。
  • 合并两组分析:谷氨酰胺随年龄升高、随皮质萎缩降低;肌醇随年龄降低、随ADC中位数升高。

关键数值与推荐

  • 谵妄诊断采用DSM-5。
  • 衰弱评估采用临床衰弱量表,谵妄组中位数5 vs 非谵妄组4.5(P=.049)。
  • 谷氨酸组间差异P=0.024(通用线性模型,以MRS体素ADC校正白质病变效应)。

临床怎么用

  • 对住院老年谵妄患者可关注入院前衰弱评估(临床衰弱量表)。
  • 脑谷氨酸升高作为谵妄的潜在可干预代谢靶点,目前仅属研究性发现,尚不宜直接用于临床决策。

局限性

  • 38名参与者中仅25人完成MRS方案,样本量小。
  • 为病例对照设计,无法确定代谢改变与谵妄的因果方向。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Delirium is common in hospitalised older people and is associated with a poor prognosis. It remains poorly characterised at a molecular level. We studied the metabolic signature of delirium using 1H-Magnetic Resonance Spectroscopy (MRS) in a prospective case-control study. METHODS: Medical inpatients aged ≥65 with and without delirium (DSM-5) were recruited and assessed for illness severity, frailty and prior cognitive decline. Metabolite concentrations in parietal white matter were obtained using MRS with diffusion MRI used to assess structural changes via the ADC. RESULTS: Out of 38 participants, 25 completed the MRS protocol (13 males and 12 females, mean age 80.5, SD = 6.47). Patients with delirium (n = 13) had greater pre-admission frailty than those without (n = 12) (median Clinical Frailty Scale 5 vs. 4.5; P = .049). There were no significant differences in age, sex, measures of MRS quality, atrophy and white matter disease. In a General Linear Model using the MRS voxel ADC to account for white matter lesion effects, glutamate was higher in delirium patients (P = 0.024). There were no other between-group differences in metabolite concentrations. For patients with and without delirium combined, glutamine increased with age and decreased with cortical atrophy, whilst Myo-inositol decreased with age and increased with median ADC. CONCLUSIONS: Our results suggest that delirium is characterised by elevated brain glutamate concentration. This could cause excitotoxic brain injury and contribute to post-delirium cognitive decline and is a potentially modifiable process that merits further investigation.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Richardson D, Mahmood A, Binnie L, et al. Magnetic resonance spectroscopy in hospitalised older people shows age and delirium-specific metabolic changes. Age Ageing. 2026. PMID: 41627307. doi:10.1093/ageing/afag013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。